from: Boshoff et al (2004). The transcriptional responses of Mycobacterium tuberculosis to inhibitors of metabolism. J Biol Chem.

Gene Expression Profile for Rv3020c/esxS

LFCtreatmentdescriptionclass of inhibitor

-2.065

Amikacinug/mL Amikacintranslation

-2.552

Cap5-10ug/mL Capreomycintranslation

-3.369

Rox10-50 ug/mL Roxithromycintranslation

-1.374

SM2-5 ug/mL Streptomycintranslation

-2.771

Tet5-10 ug/mL Tetracyclinetranslation

-0.676

Rif0.2-5ug/mL Rifampicintranscription

-1.105

Rifp0.1-0.5ug/mL Rifapentinetranscription

-0.521

Min_med__succinate_Minimal medium with succinate as sole carbon source as compared to growth in 7H9/ADC/Tween/glycerolstarvation

0.014

CCCP10-50 uM Carbonyl cyanide 3-chlorophenylhydrazonerespiration

-0.038

CPZ10-50 ug/mL Chlorpromazinerespiration

2.466

Clofazimine10-13 ug/mL Clofaziminerespiration

-0.007

Clotrimazole10-24 ug/mL Clotrimazole (azole drug)respiration

0.512

DCCD20-100 uM Dicyclohexylcarbodiimiderespiration

0.049

DNP"0.5-2.5 mM 2,4-Dinitrophenol"respiration

-0.564

DTT"1-2 mM 1,4-Dithio-DL-threitol"respiration

-0.065

Econazole10-24 ug/mL Econazole (azole drug)respiration

1.897

GSNO_CFZ0.1 mM S-Nitrosoglutathione + 5 ug/mL Clofaziminerespiration

-0.059

GSNO_CPZ0.1 mM S-Nitrosoglutathione + 20-25 ug/mL Chlorpromazinerespiration

0.409

GSNO_KCN0.1mM S-Nitrosoglutathione + 5ug/mL potassium cyaniderespiration

-0.045

GSNO_menadione0.1 mM S-Nitrosoglutathione + 6-10 ug/mL menadionerespiration

-0.298

KCN5-20 ug/mL Potassium cyaniderespiration

0.009

NaN30.2-2 mM Sodium aziderespiration

-0.370

Nigericin50 uM Nigericinrespiration

-0.186

TRC10-150 ug/mL Triclosanrespiration

0.216

TRZ10-25 ug/mL Thioridazinerespiration

-1.010

Valinomycin0.5-10 uM Valinomycinrespiration

-0.920

ZnSO42 mM ZnSO4respiration

-0.794

menadione6-10 ug/mL Menadionerespiration

1.823

Ascididemin_Nat_prod4-9 ug/mL Organic extract of Eudistoma amplumironLimitation

1.467

Deferoxamine150-250 uM Deferoxamine mesylateironLimitation

1.963

Dipyridyl"100-200 uM 2,2'-Bipyridyl"ironLimitation

0.425

GSNO0.02-0.1mM S-NitrosoglutathionedosRassociated

-0.476

NRP_1Non-replicating persistence stage 1dosRassociated

0.214

Amp0.2mg/mL AmpicillincellWall

0.413

Cephalexin20-100 ug/mL CephalexincellWall

0.684

Cerulenin0.32-5 ug/mL CerulenincellWall

-0.461

DIPED5-100 ug/mL DiisopropylethylenediaminecellWall

0.400

EMB10-20 ug/mL EthambutolcellWall

0.498

Eta12-40 ug/mL EthionamidecellWall

0.783

INH0.2-0.4 ug/mL IsoniazidcellWall

0.575

TLM0.1-0.2 mg/mL ThiolactomycincellWall

-0.140

PalmitateMinimal medium with palmitate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

0.191

SuccinateMinimal medium with succinate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

-0.257

BZA0.12 mg/mL BenzamidearomaticAmides

-0.065

Nam0.12 - 1.2 mg/mL NicotinamidearomaticAmides

0.250

PZA0.12-1.2 mg/mL PyrazinamidearomaticAmides

0.336

H2O24 mM hydrogen peroxideDNAdamaging

-1.103

Levo10 ug/mL LevofloxacinDNAdamaging

0.335

Mtm0.1-0.2 ug/mL Mitomycin CDNAdamaging

1.482

Novobiocin10 ug/mL NovobiocinDNAdamaging

-0.362

Oflox5-10 ug/mL OfloxacinDNAdamaging

0.433

UVUV-irradiationDNAdamaging

0.486

ARP41-4 ug/mL Antitubercular compound ARP4?

0.259

Antimycin12.5-50 ug/mL Antimycin A?

0.171

DTNB"1-2 mM 5,5'-Dithiobis(2-nitrobenzoic acid)"?

0.536

PA_110-50 ug/mL Antitubercular compound PA-1?

0.256

PA_2110-50 ug/mL Antitubercular compound PA-21?

-0.915

PA8240.2-2 ug/mL PA-824?

-1.706

Procept_677620-30 ug/mL Antitubercular compound Procept 6776?

-0.645

Procept_67785-40 ug/mL Antitubercular compound Procept 6778?

0.346

Verapamil50 uM Verapamil?

0.546

mercaptoethanol2 mM 2-Mercaptoethanol?

-0.061

methoxatin10-20 ug/mL Methoxatin?